The Skin Care Campaign

 

The Skin Care Campaign (SCC) is an umbrella organisation representing the interests of all people with skin diseases in the UK . Established in 1992, it is a subsidiary of the National Eczema Society, a registered charity.

INCLUSIVENESS

The SCC is by nature inclusive. Forum meetings, generally held three times a year, provide opportunities for the Campaign's member organisations, its professional participants and its supporters to raise and discuss skin health issues and to prioritise the Campaign's activities. Voting rights are limited to the member organisations and objectives and activities are reviewed and agreed by the SCC Board.

MEMBERSHIP

Membership of the SCC is open to all UK national patient organisations representing people affected by skin conditions and whose applications are approved by the SCC's Board.

PROFESSIONAL PARTICIPATION

With its firm base in voluntary groups, the SCC is able to draw on a huge resource of patient-based knowledge and experience. It combines this with advice and support from health professionals' organisations including the British Association of Dermatologists, the British Association of Plastic Surgeons, the British Dermatological Nursing Group, the Primary Care Dermatology Society, the Royal College of Nursing, and the Royal Pharmaceutical Society of Great Britain.

 

CORPORATE SUPPORT

The SCC values greatly the support and sponsorship it receives from a substantial number of companies, and the experience and expertise they contribute. The SCC's supporters participate actively in Forum meetings and exhibit at Skin Information Days.

THE SCC'S OBJECTIVES

  • to work for the improvement of health care for people with skin disease;
  • to educate and inform the public and others about skin diseases and their treatment; and
  • to support other organisations in order to pursue these objectives.

 

To these ends, it:

  • makes recommendations for improvements in dermatology services to Parliament, through the All Party Parliamentary Group on Skin, and directly to the Department of Health and to other health service providers;
  • participates actively in government and other initiatives to improve dermatology services;
  • runs media campaigns directed at health professionals and the public, to raise awareness of dermatology within the medical profession;

 

 

Recent successes by the SCC have included:

•  securing government funding for a national UV health promotion campaign, being run as the SunSmart Campaign by Cancer Research UK;
•  having funded and commissioned a high quality dermatology course for nurses in primary care;
•  having run successful campaigns, chiefly to pharmacists, to promote the need for the widest possible range of treatments to be available for the treatment of skin diseases, on prescription, at appropriate levels within the NHS;
•  having Skills for Health’s Dermatology Workforce Team established to develop new patient journeys in dermatology, to recommend to the Department of Health what should be the workforce to deliver those journeys and what competencies needed by that workforce;
•  obtaining recognition by the DH that most skin diseases are chronic illnesses and, as such, that they should be included in all initiatives to improve chronic disease management;
•  with its member organisations, providing patients’ perspectives on a wide range of issues in response to a wide range of government consultations, including several NICE Health Technology Appraisals.

 

Despite these successes, the SCC still has much more to do. Key activities in 2006/07 include:

•  promoting best practice in primary care, chiefly through the Dermatology Workforce Group;
•  improving dermatology training for health professionals;
•  obtaining an appropriate increase within the NHS of the numbers of health professionals and associated resources needed to deliver high quality dermatology services;
•  assuring the availability on prescription of the widest possible range of treatments for skin diseases; and assuring that where a person with a skin disease may be expected to benefit from a particular treatment licensed for that indication, that treatment is available to them;
•  educating health professionals and the public about the prevention and treatment of skin diseases, and removing the stigma associated with them;
•  assuring that chronic conditions and the quality of life issues associated with them are accorded appropriate importance by health service providers

 

 

Two Steps Forward, One Step Back

In March 2005, Berkeley Greenwood , for the All-Party Parliamentary Group on Skin, Professor Chris Griffiths and Dr Robin Graham-Brown for the British Association of Dermatologists (BAD), and Peter Lapsley for the Skin Care Campaign, met the Deputy Chief Medical Officer, Professor Aiden Halligan and two of his colleagues to discuss with them some of the problems faced by people with skin diseases and by dermatology more generally.

We explained that, typically, skin disease represents between 15 and 20% of a GP’s workload, that inflammatory skin diseases such as acne, eczema and psoriasis make up some 70% of all skin disease seen in primary care, and that the incidence of some skin diseases – notably eczema and skin cancer – is increasing markedly. We pointed also to the evidence showing that many skin diseases, including acne, eczema and psoriasis can result in disability levels equivalent to or greater than those experienced by patients with diseases such as angina, asthma, arthritis, back pain, bronchitis, diabetes and hypertension.

We said we welcomed the outcomes from the NHS Modernisation Agency’s Action on Dermatology (AOD) programme, which had recommended inter alia that more dermatology should be carried out in primary care. We welcomed also the work being undertaken by the Dermatology Workforce Group (DWG) to build on the foundations laid by AOD.

We provided Professor Halligan with a simple, revised patient journey in dermatology (fig 1), which had been developed by the DWG. Focusing on the well supported self-management of much inflammatory skin disease, it offers real benefits both to patients and to the NHS. We also told Professor Halligan that, with Skills for Health, the Dermatology Group was embarking on the development of competency frameworks for health professionals concerned with dermatology.

Professor Griffiths told Professor Halligan that the NHS Alliance and the BAD are in advanced discussions to improve and strengthen interactions between primary and secondary providers of dermatology services. He said also that Professor Carol Black, President of the Royal College of Physicians. Had been involved in these discussions.

We identified to Professor Halligan the chief obstacles to implementation of the necessary changes in dermatology as being:

•  a dearth of dermatology training for primary care health professionals; and

•  a lack of incentive for GPs to improve dermatology services.

 

We explained that the lack of dermatology training was being addressed through collaboration between the BAD and the RCGP in the development of a new dermatology curriculum for GPs, to be included as an exemplar in the new GP curriculum; through the development of a new dermatology course for practice nurses; and through revision of the dermatology module of pharmacists’ CPPE.

We said that the obvious way to provide GPs with an incentive to improve their dermatology services would be to have appropriate Quality and Outcomes measures incorporated into the new GMS contract.

Professor Halligan agreed that it should be possible to resolve these issues and subsequently wrote to Dr David Colin-Thome, the National Director for Primary Care, and Dr Mike Dixon, Chairman of the NHS Alliance, asking them to meet us to explore what might be done to that end.

Additionally, Professor Halligan said he had asked his Assistant Medical Director, Dr Sean O’Kelly, to act as the liaison case officer for dermatology issues and as our first point of contact with DH, and he gave us a comprehensive list of people to contact, with his support, with a view to facilitating the inclusion of Quality and Outcome measures for dermatology in the GMS contract and to moving forward with the self-management of inflammatory skin diseases.

During a discussion of academic medical careers and wider training issues, Professor Griffiths said that the BAD was already in contact with Professor Alan Crockard of Modernising Medical Careers and intends to maintain that link.

Overall, this seemed to us at the time to be a very constructive meeting not least because the DCMO agreed that it would be helpful for us all to meet again in six months, or so, to review the progress that we have made. It was disappointing, therefore, to learn no more than a month or six weeks later that Professor Halligan had stepped down from the DCMO post, that Dr Sean O’Kelly’s contract with the Department was being ended and that, therefore, we no longer had a formal point of contact after all.

So, in that vital respect, it is ‘back to the drawing board’; we are asking the Chief Medical Officer to rectify this serious hiccup in our relationship with the Department. In the meantime, we are following up the contacts the DCMO gave us. And, with the DWG and the BAD, we have co-submitted a proposal for a dermatology Quality and Outcomes Framework to be included in the revised GP Contract which will be published in 2006. The basis for that proposal may be seen at (click on here).

 

 

Figure 1:  Revised Patient Journey

 

 

Atopic eczema, psoriasis and acne: common chronic skin conditions that constitute a burden to general practice

This is the text of a briefing paper prepared in February 2005 for Professor Carol Black, President of the Royal College of Physicians, by Professor David Gawkrodger and Dr Mark Goodfield on behalf of the Joint Specialty Committee for Dermatology. It was used in May 2005 as the basis for a submission proposing the inclusion of a Quality and Outcomes Framework during revision of the GP Contract

The improved management of chronic or long term conditions in community based programmes of care now forms an important element in government policy. Skin problems form part of around 15% of all consultations in general practice in the UK (RCGP, 1995). There are more referrals by GPs to Dermatologists than to the rest of General Medicine in total, and 20% of all referrals to hospital are for the 3 major inflammatory conditions (eczema, psoriasis and acne). Despite these well-documented figures, skin disorders do not feature in the quality frameworks for the new GMS contract that now drive priorities in primary care.

Foremost among the skin diseases that burden general practice are atopic eczema, which accounts for 30% of GP consultations due to skin disease (Rea et al, 1976), psoriasis and acne. The diagnosis of these conditions in their classical form is usually straightforward, but management is often poor, ill focussed and unnecessarily expensive. Patients and carers are often well informed, and highly motivated, but find difficulty accessing practical information and informed medical practitioners to facilitate their self-management.

Eczema

•  The prevalence of atopic eczema has risen over the last few decades so that it now affects 15% of infants in the UK (Kay et al, 1994)

•  The impact of the disease on family life is greater than that produced by any of the other chronic disorders including asthma and diabetes.

•  10% of all referrals to hospital are of patients with eczema.

•  Management strategies are well documented, and guidelines of care exist, but patients and parents require guidance and help with the practicalities of management.

•  Nurse led clinics and enhanced general practitioner roles produce a significant impact on the management of the disorder, improve self-reliance and reduce the need for hospital referral.

•  Almost all of these affected children will have concomitant asthma, and may already be seen by the community based nurse specialists because of their pulmonary disease: failure to deal with their cutaneous problems at the same time is a missed opportunity, but requires educational input for the nurses, as well as additional time for consultation.

•  Adequate medical support is also essential, but will produce improved quality of outcome as well as reducing hospital referral and enhancing patient self-management.

•  Both the Dermatology Sub-group of the Long Term Conditions Care group and the Children’s’ NSF advocate community care for these patients, but progress is limited by the lack of a primary care focus.

•  In the smaller adult population with eczema, dermatitis is the second commonest cause of absence from work after musculo-skeletal disorders, and whilst there may be more factors influencing the disease, the principles of management are the same.

Psoriasis

•  Psoriasis affects 1.6-2% of the British population UK (Kidd and Meenan, 1961; Rea et al, 1976).

•  The condition produces severe social and psychological consequences and reduces quality of life significantly (Finlay and Coles, 1995). It is lifelong.

•  In its most severe form it is life threatening, but for the majority of patients with mild disease, simple topical therapies work well provided that the treatments are used appropriately.

•  5% of all referrals to hospital-based Dermatology will have psoriasis.

•  Misinformation and poor compliance are major features in poor management of the disease, and currently 50% of sufferers will require hospital management over a 5-year period.

•   Nurse led clinics reduce the need for consultant appointments and improve patient care.

 

Acne

•  Acne is the third of the major inflammatory dermatoses.

•  80% of teenagers suffer at some time, and by mid twenties, 1% of men and nearly 30% of women still suffer.

•  Treatment options are well known, guidelines are in development, and yet 5% of all dermatology referrals are for patients with acne, and 50% of these will have received sub-optimal therapy (often none).

•  Nurse-led guideline based care will produce more effective treatment and more rational prescribing.

 


Case for inclusion of skin disease in the GP contract

 

•  Skin disorders represent a chronic burden to GPs in terms of numbers of patients seen, time spent with patients, and prescription of drugs.  

•  Despite this, patient management is often poor, patients are unhappy with their care, and find difficulty in self-managing.  

•  The education of GPs in dermatology is sub-optimal (APPGS, 2002). There is good reason for more attention to be paid to training and assessing of GPs in skin disease. Any programme of enhanced primary care must deliver appropriate educational opportunities for doctors and nurses.  

•  Contact with nurses, and improved vertical integration between primary and secondary care enhances self care, and the benefit, is assessable in terms of

•  Hospital referral

•  Use of guidelines

•  Appropriate prescribing

 

•  We suggest the use of the following quality statements:

 

Records - suggested threshold 90%

 

SKIN 1. Practices will have a register of patients with atopic eczema and a register of patients with psoriasis.

 

Ongoing management - suggested threshold 70%

 

SKIN 2. The percentage of patients with atopic eczema offered a consultation with a trained nurse to receive advice, educational material and a review of treatment.

SKIN 3. The percentage of patients with psoriasis offered a consultation with a trained nurse to receive advice, educational material and a review of treatment.

SKIN 4. Practices will have in use a protocol, agreed with the local secondary care provider or appropriate national body, for the treatment of patients with acne.

 

References

All Party Parliamentary Group on Skin: Report on the Enquiry into Primary Care Dermatology Services. London , APPG, 2002.

Eun HC, Finlay AY. Measurement of atopic dermatitis disability. Ann Dermatol 1990; 2: 9-12.

Finlay AY, Coles EC. The effect of severe psoriasis on the quality of life in 369 patients. Br J Dermatol 1995; 132: 236-44.

Gawkrodger DJ. Dermatology: an Illustrated Colour Text, 3 rd ed. Edinburgh , Churchill Livingstone, 2002.

Henseler T, Christophers E. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol 1985; 13: 450-6.

Herd RM, Tidman MJ, Prescott RJ, Hunter JAA. Prevalence of atopic eczema in the community: the Lothian atopic eczema study. Br J Dermatol 1996; 135: 18-19.

Kay J, Gawkrodger DJ, Mortimer MJ, Jaron A. The prevalence of childhood atopic eczema in a general population. J Am Acad Dermatol 1994; 30: 35-9.

Kidd CB, Meenan JC. A dermatological survey of long-stay mental patients. Br J Dermatol 1961; 73: 129-33.

Lewis-Jones MS, Finlay AY. The children’s dermatology life quality index (CDLQI): initial validation and practical use. Clin Exper Dermatol 1995; 20: 38-41.

Rea JN, Newhouse ML, Halil T. Skin disease in Lambeth. Br J Prev Soc Med 1976; 30: 107-14.

Royal College of General Practitioners. Morbidity Statistics from General Practice: Fourth National Study 1991-92. London , HMSO, 1995.

Steele K. Primary dermatological care in general practice. J Roy Coll Gen Pract 1984; 34: 22-24.

 

The All Party Parliamentary Group on Skin

 

The All Party Parliamentary Group on Skin (APPGS) was established in 1994, the culmination of an SCC campaign to raise awareness of skin disease in Parliament. Around 400 All Party Parliamentary Groups exist, representing a variety of public policy issues.

 

The APPGS has a large and active membership that includes MPs from all political parties, members of the House of Lords, health professionals, patient groups and commercial interests.

 

The Group’s day-to-day activities are determined by its Steering Group, which is composed of non-parliamentary members and is representative of the associate membership. All activities are subject to the approval of the Group’s parliamentary officers led by the Chairman, the Rt Hon Bruce George MP.

 

The APPGS has the following broad objectives:

 

•  to raise awareness of skin issues in Parliament
•  to achieve improvements in the treatment and management of patients with skin disease
•  to provide an unbiased means of responding to threats to dermatology
•  to provide a forum for partners in skin care – patients, clinicians, managers, industry and other skin interested organisations
•  to make recommendations to Government for improvements to dermatology services and patient management

 

The APPGS holds around five meetings a year in the House of Commons to inform parliamentarians about relevant dermatology issues. A variety of speakers address the Group including representatives from health professional organisations, patient groups, political parties and charities. Meetings are open to all members and provide an opportunity to share information and experiences.

 

The APPGS also produces written reports, to which all members have the opportunity to contribute. Nine reports have been published to date, addressing a variety of dermatology issues including the adequacy of service provision, two on dermatology training for health professionals, fraudulent practice, primary care, skin cancer, the elderly, and the impact of skin disease on people’s lives. The Group’s reports have been widely supported by dermatology stakeholders and have proved useful tools for presenting evidence to policy makers.

 

The APPGS also undertakes ad hoc briefing activity to highlight new and emerging issues with its parliamentary members. This includes liaising with MPs and Peers on parliamentary questions, early day motions and short debates. The Group will also raise issues with officials in Whitehall as and when appropriate.

 

The APPGS’s work programme is intended to reflect key issues in dermatology services and emerges from consultation with key dermatology stakeholders. The Group’s priorities have included securing a dermatology policy lead in the Department of Health, work to implement the training report, as well as having dermatology included in the GP Contract.

 

The first part of 2005 saw the APPGS starting work on its tenth report, to be published towards the end of year. The report will address the adequacy and equity of dermatology service provision, highlighting new developments in primary care dermatology services and updating the 1997 report.

 

Membership of the All Party Parliamentary Group on Skin is open to any organisation or individual with an interest in Skin Disease. If you would like to become an associate member of the Group please contact the Secretariat.

 

All Party Parliamentary Group on Skin

St James House, 13 Kensington Square, London, W8 5HD

Tel: 020 7368 3100   Fax: 020 7368 3101  Email: info@portcullispublicaffairs.com

Click to go to the Home Page
Click to go to the Skin Conditions Page

Click to go to the Media Centre Page
Click to go to the FAQs Page
Click to go to the Resources & Links Page